← Leaderboards
Oliver Bogler
Henry Ford Health System
$5,563,684
Attributed
$5,563,684
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $973K · FY2005–12$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$5,563,684 · 7
By mechanism
R01$3,926,566 · 4
P50$1,340,643 · 2
R21$296,475 · 1
Top collaborators
No co-investigators on record.
Most similar at Henry Ford Health System
Same institution · by research overlap
- Shulin Li$17,068,216
- Zheng Gang Zhang$14,094,277
- Qing-Sheng Mi$11,290,442
- Hari K. Koul$6,359,854
- Svend O Freytag$5,645,392
Others in their field
Top investigators on “Brain Neoplasms”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,967,203
- David Heimbrook · Leidos Biomedical Research, Inc.$145,442,397
- Walter John Curran · Thomas Jefferson University$98,312,615
- Gregory H Reaman · National Childhood Cancer Foundation$78,833,655
- Todd A Alonzo · University Of Colorado Denver/Hsc Denver$72,436,447
- Robert H Vonderheide · University Of Pennsylvania$60,987,353
Research focus
Brain NeoplasmsProgramsGliomaApoptosisResearch PersonnelMalignant Neoplasm Of BrainBaseLeadResourcesMolecularCellsSignal TransductionProgress ReportsMediatingInsightPathway InteractionsGlioblastomaDesignCell DeathBinding (Molecular Function)Athymic MouseEpidermal Growth Factor ReceptorAffectCombined Modality Therapy
Grant awards (29)
Polynuclear Platinums in Targeted and Combination Glioma Therapy$254,522
R01 · FY2012 · CA · contact PI
Developmental Research program$144,228
P50 · FY2012 · CA · contact PI
CA: Administrative Core$143,445
P50 · FY2012 · CA · contact PI
Polynuclear Platinums in Targeted and Combination Glioma Therapy$254,522
R01 · FY2011 · CA · contact PI
Developmental Research program$142,915
P50 · FY2011 · CA · contact PI
CA: Administrative Core$142,143
P50 · FY2011 · CA · contact PI
Polynuclear Platinums in Targeted and Combination Glioma Therapy$262,394
R01 · FY2010 · CA · contact PI
Developmental Research program$143,763
P50 · FY2010 · CA · contact PI
CA: Administrative Core$142,984
P50 · FY2010 · CA · contact PI
Polynuclear Platinums in Targeted and Combination Glioma Therapy$262,394
R01 · FY2009 · CA · contact PI
Developmental Research program$143,139
P50 · FY2009 · CA · contact PI
CA: Administrative Core$142,364
P50 · FY2009 · CA · contact PI
Treatment of Malignant Gliomas with 2-5A-anti-hTR$293,510
R01 · FY2008 · CA · contact PI
Polynuclear Platinums in Targeted and Combination Glioma Therapy$270,000
R01 · FY2008 · CA · contact PI
Regulation of RTKs by the SETA/CIN85 Complex in Glioma$213,815
R01 · FY2008 · CA · contact PI
Developmental Research program$98,097
P50 · FY2008 · CA · contact PI
CA: Administrative Core$97,565
P50 · FY2008 · CA · contact PI
Treatment of Malignant Gliomas with 2-5A-anti-hTR$293,510
R01 · FY2007 · CA · contact PI
Regulation of RTKs by the SETA/CIN85 Complex in Glioma$213,815
R01 · FY2007 · CA · contact PI
Regulation of RTKs by the SETA/CIN85 Complex in Glioma$220,201
R01 · FY2006 · CA · contact PI
Proteomic Study of Novel Platinum Compounds in Glioma$146,475
R21 · FY2006 · CA · contact PI
Regulation of RTKs by the SETA/CIN85 Complex in Glioma$237,688
R01 · FY2005 · CA
Proteomic Study of Novel Platinum Compounds in Glioma$150,000
R21 · FY2005 · CA
APOPTOSIS AND A NEW ADAPTER MOLECULE PATHWAY IN GLIOMA$227,334
R01 · FY2004 · CA
Regulation of RTKs by the SETA/CIN85 Complex in Glioma$172,603
R01 · FY2004 · CA
Regulation of RTKs by the SETA/CIN85 Complex in Glioma$80,226
R01 · FY2004 · CA
APOPTOSIS AND A NEW ADAPTER MOLECULE PATHWAY IN GLIOMA$225,300
R01 · FY2003 · CA
APOPTOSIS AND A NEW ADAPTER MOLECULE PATHWAY IN GLIOMA$223,325
R01 · FY2002 · CA
APOPTOSIS AND A NEW ADAPTER MOLECULE PATHWAY IN GLIOMA$221,407
R01 · FY2001 · CA